Selected Publications

Floberg JM, Wang L, Bandara N, Rashmi R, Mpoy C, Garbow JR, Rogers BE, Patti GJ, Schwarz JK  Altering cellular reducing potential changes 64Cu-ATSM signal with or without hypoxia. J Nucl Med. 2019 Oct 4. pii: jnumed.119.230805. doi: 10.2967/jnumed.119.230805. [Epub ahead of print]  PMID: 31586008

Amy J. WisdomCierra S. HongAlexander J. LinYu XiangDaniel E. CooperJin ZhangEric S. XuHsuan-Cheng KuoYvonne M. MoweryDavid J. CarpenterKushal T. KadakiaJonathon E. HimesLixia LuoYan MaNerissa WilliamsDiana M. CardonaMalay HaldarYarui DiaoStephanie MarkovinaJulie K. Schwarz, and David G. Kirsch   Neutrophils Promote Tumor Resistance to Radiation Therapy.

Panni RZ, Herndon JM, Zuo C, Hegde S, Hogg GD, Knolhoff BL, Breden MA, Li X, Krisnawan VE, Khan SQ, Schwarz JK, Rogers BE, Fields RC, Hawkins WG, Gupta V, DeNardo DG. Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies. Science Translational Medicine. July 3, 2019. DOI: 10.1126/scitranslmed.aau9240

Rashmi R, Huang X, Floberg JM, Elhammali A, McCormick ML, Patti GJ, Spitz DR, Schwarz JK*. Radio-resistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism. Cancer Res. 2018 Jan 16. [Epub ahead of print]

Grigsby P, Elhammali A, Ruiz F, Markovina S, McLellan MD, Miller CA, Chundury A, Ta NL, Rashmi R, Pfeifer JD, Fulton RS, DeWees T, Schwarz JK*Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancerOncotarget. 2018; 9:4061-4073.

Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.

Rashmi R, DeSelm C, Helms C, Bowcock A, Rogers BE, Rader JL, Grigsby PW, Schwarz JK*AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake. PLoS One. 2014 Apr 4;9(4):e92948.

Schwarz JK, Lewis JS, Pfeiffer J, Huetnner PC and PW Grigsby.  Prognostic significance of p16 expression in advanced stage cervical cancerInt J Radiat Oncol Biol Phys 2012 Sep 1;84(1):153-7.

Schwarz JK**, Payton JP, Pillai R, Xiang T, Jia Y, Huettner P, Rogers B, Yang Q, Watson M, Rader J and PW Grigsby.  Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancerClin Cancer Research 2012 Mar 1;18(5):1464-71.

Schwarz JK, Siegel B, Dehdashti F, Grigsby PW.  Metabolic response on posttherapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2012 May 1;83(1):185-90.

Hu X*, Schwarz JK*, Lewis JS, Rader JS, Deasy J, Grigsby PW, Wang X.  A microRNA expression signature for cervical cancer prognosis. Cancer Res. 2010 Feb 15;70(4):1441-8.

Schwarz JK, Lin L, Siegel BA, Miller TR and PW Grigsby.  18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1502-7.

Schwarz JK, Siegel BA. Dehdashti F and PW Grigsby.  Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 2007;298(19):2289-2295.

*Denotes corresponding or senior authorship.
**Article selected for journal highlight.